PCVX
$30.65
Revenue | $0Mn |
Net Profits | $-137.08Mn |
Net Profit Margins | -Inf% |
Vaxcyte Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Vaxcyte Inc has generated NaN% jump in its revenue since last 3-months.
Vaxcyte Inc’s net profit jumped 24.18% since last year same period to $-137.08Mn in the Q4 2024. On a quarterly growth basis, Vaxcyte Inc has generated -32.93% fall in its net profits since last 3-months.
Vaxcyte Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Vaxcyte Inc has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.99 |
EPS Estimate Current Year | -0.99 |
Vaxcyte Inc’s earning per share (EPS) estimates for the current quarter stand at -0.99 - a 12.21% jump from last quarter’s estimates.
Vaxcyte Inc’s earning per share (EPS) estimates for the current year stand at -0.99.
Earning Per Share (EPS) | -1.02 |
Vaxcyte Inc’s earning per share (EPS) jumped 44.09% since last year same period to -1.02 in the Q4 2024. This indicates that the Vaxcyte Inc has generated 44.09% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-06 | -0.98 | -1.1 | -12.24% |
2025-02-25 | -0.99 | -1.02 | -2.58% |
2024-05-08 | -1.17 | -0.85 | 27.35% |
2024-11-05 | -1.13 | -0.83 | 26.55% |